Imaging agent - PDFSEARCH.IO - Document Search Engine

Imaging agent
Results: 111

#	Item
81	The Benefit of High Field MRI to quantify Myeloperoxidase Activity using a Gd-DTPA Derivated Contrast Agent Bernhard Obereder Oregon Health and Science University Add to Reading List Source URL: marshallplan.squarespace.com Language: English - Date: 2011-01-30 18:26:53 Gadolinium Pentetic acid Magnetic resonance imaging Relaxation Myeloperoxidase Gadobenic acid Nuclear magnetic resonance Horseradish peroxidase Chemistry Matter Gadopentetic acid
82	ONC-2R-OSLO WARING: NEPHROGENIC SYSTEMIC FIBROSIS Gadolinium-based contrast agents increase the risk for nephrogenic systemic fibrosis (NSF) in patients with: . acute or chronic severe renal insufficiency Cglomerular fi Add to Reading List Source URL: www.accessdata.fda.gov Language: English - Date: 2009-03-31 14:43:12 Gadolinium Gadopentetic acid Nephrogenic systemic fibrosis Magnetic resonance imaging MRI contrast agent Chemistry Matter Gadodiamide
83	NCIDEA: Board of Scientific Advisors: June 26-27, 2003 Meeting Add to Reading List Source URL: deainfo.nci.nih.gov Language: English - Date: 2010-03-01 09:44:14 National Institutes of Health Cancer research National Cancer Institute Ralph Weissleder Hedvig Hricak Andrew von Eschenbach Molecular imaging Imaging agent War on Cancer Medicine Cancer organizations Oncology
84	the RECORDER American Neurogastroenterology and Motility Society Spring 2013 • Volume 2 • Number 1 Add to Reading List Source URL: www.motilitysociety.org Language: English - Date: 2013-05-03 22:19:20 Neurogastroenterology SmartPill Prokinetic agent Intestinal pseudoobstruction Manometry Irritable bowel syndrome Given Imaging Medicine Health Gastroenterology
85	ProHance(8 Multipack™ (Gadoteridol) Injection, 279.3 mg/mL Pharmacy Bulk Package -...Page 1 of9 Prohance Multipack (gadoteridol) Injection, Solution (Bracco Diagnostics Inc. i Pharmacy Bulk Package - Not for Direct I Add to Reading List Source URL: www.accessdata.fda.gov Language: English - Date: 2009-03-31 14:43:14 Gadodiamide Nephrogenic systemic fibrosis Gadopentetic acid Gadoteridol Gadolinium Magnetic resonance imaging Aspirin MRI contrast agent Chemistry Matter Medicine
86	U.S. Food and Drug Administration Notice: Archived Document The content in this document is provided on the FDA’s website for reference purposes only. It was current when produced, but is no longer maintained and may Add to Reading List Source URL: www.fda.gov Language: English Gadolinium Gadodiamide Gadopentetic acid Nephrogenic systemic fibrosis Magnetic resonance imaging Chronic kidney disease Food and Drug Administration Jonathan L. Halperin MRI contrast agent Chemistry Medicine Matter
87	MAGNEVIST® (brand of gadopentetate dimeglumine) Injection Add to Reading List Source URL: www.accessdata.fda.gov Language: English - Date: 2013-10-18 16:38:56 Gadolinium Nephrogenic systemic fibrosis Magnetic resonance imaging Pentetic acid MRI contrast agent Gadodiamide Chemistry Matter Gadopentetic acid
88	FOOD AND DRUG ADMINISTRATION Add to Reading List Source URL: www.fda.gov Language: English Gadolinium Gadopentetic acid Gadodiamide Magnetic resonance imaging Center for Drug Evaluation and Research Bayer MRI contrast agent Chemistry Matter Food and Drug Administration
89	MAGNEVIST (( (brand of gadopentetate dimeglumine[removed]Injection Add to Reading List Source URL: www.accessdata.fda.gov Language: English - Date: 2009-03-31 14:42:48 Gadolinium Gadodiamide Magnetic resonance imaging Nephrogenic systemic fibrosis Pentetic acid Functional magnetic resonance imaging MRI contrast agent Chemistry Matter Gadopentetic acid
90	GE Healthcare 101 Carnegie Center Princeton, New Jersey[removed]USA June 6, 2006 Add to Reading List Source URL: www.fda.gov Language: English Nephrogenic systemic fibrosis Nephrology Gadodiamide MRI contrast agent Gadolinium Magnetic resonance imaging General Electric Contrast medium Chemistry Matter Medicine

UPDATE